| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 01/22/2008 | CA2365237C Method for synthesis of polypeptides in cell-free systems |
| 01/17/2008 | WO2008008975A2 Refolding of recombinant proteins |
| 01/17/2008 | WO2008007146A1 Process for preparing particles of proteinaceous material |
| 01/17/2008 | WO2008006899A1 One step imac (mcac) purification of proteins |
| 01/17/2008 | WO2007062150A3 Leukotoxin compositions and therapeutic methods |
| 01/17/2008 | WO2006105490A3 Compositions and methods for treating diseases associated with phlpp |
| 01/17/2008 | WO2006091861A3 Compositions and methods relating to cns lymphoma |
| 01/17/2008 | WO2005089110A3 Polynucleotide synthesis |
| 01/17/2008 | WO2003004615A3 Secreted proteins |
| 01/17/2008 | US20080015341 New hydrophobic polymer comprising fluorine moieties |
| 01/17/2008 | US20080015340 Fusion protein of antigens from parainfluenza virus (PIV) and respiratory syncytial virus (RSV); single recombinant immunogen can protect susceptible individuals against diseases caused by both PIV and RSV |
| 01/17/2008 | US20080015152 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive, eating and nervous system disorders |
| 01/17/2008 | CA2657277A1 Process for preparing particles of proteinaceous material |
| 01/17/2008 | CA2656835A1 Refolding of recombinant proteins |
| 01/16/2008 | EP1878739A1 One step IMAC (MCAC) purification of proteins |
| 01/16/2008 | EP1877437A2 Chimeric proteins with phosphatidylserine binding domains |
| 01/16/2008 | EP1877420A1 Combination therapy in the treatment of cancer |
| 01/16/2008 | EP1877079A2 Plant-derived elastin binding protein ligands and methods of using the same |
| 01/16/2008 | EP1711511B1 Method for crystallization of proteins using polysaccharides |
| 01/16/2008 | EP1613644A4 Peg-physiologically active polypeptide homodimer complex having prolonged in vivo half-life and process for the preparation thereof |
| 01/16/2008 | EP1107969B1 Collections of compounds |
| 01/16/2008 | CN101107007A GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 01/16/2008 | CN101104638A Solid phase synthetic technique for thymosin alpha1 |
| 01/16/2008 | CN101104635A Method for purifying recombination human alpha-whey albumin from transgene cow milk |
| 01/16/2008 | CN100362016C Vegetable protein as well as preparation method and application |
| 01/16/2008 | CN100362015C Method for separating and extracting protein and/or enzyme from ion liquid |
| 01/15/2008 | US7319143 Genetically-engineered MHC molecules |
| 01/15/2008 | US7319136 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 01/15/2008 | US7319135 PRO1341 polypeptides |
| 01/15/2008 | US7319021 A cationic or nonionic surfactant having a hydrophobic-lipophilic balance value from about 11 to 16 and a cell membrane altering compound, used for extracting a protein or peptide from target cell |
| 01/15/2008 | US7319010 Detection and treatment of cancers of the colon |
| 01/15/2008 | US7319002 Using 2-3,O-sialic acid immobilized solid support to detect adenoviral infection; pathogen diagnostics |
| 01/15/2008 | US7318922 Anti-PRO5337 antibodies |
| 01/15/2008 | CA2301854C Protein composition and process for isolating a protein composition from a muscle source |
| 01/15/2008 | CA2268014C Thermostable dna polymerase from carboxydothermus hydrogenoformans |
| 01/10/2008 | WO2008004904A1 Method for producing a mixture of amino acids and lower peptides |
| 01/10/2008 | WO2007067514A3 Methods for identifying modulators of hedgehog autoprocessing |
| 01/10/2008 | US20080010701 polynucleotides encoding polypeptides active in fructan, cellulose, starch and/or tannin biosynthetic pathways; transgenic plant cells |
| 01/10/2008 | US20080009621 Control of Cyanate in Aqueous Urea Solutions by non-1,2-Ethylene Diamine like Compounds for the Protection of Protein/Peptide Carbamylation |
| 01/10/2008 | US20080009611 Method for Producing Protein Hydrolysates |
| 01/10/2008 | US20080009610 Diagnosis and treatment of PTP related disorders |
| 01/10/2008 | US20080009604 Novel polypeptide and process for producing the same |
| 01/10/2008 | US20080009435 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
| 01/10/2008 | US20080009066 Plant gene encoding trehalose metabolism enzymes |
| 01/10/2008 | US20080009053 Modified Ethylenediamine-N, N'-Disuccinate: Ethylnediamine Lyase |
| 01/10/2008 | US20080008709 Conjugation of biomolecules using Diels-Alder cycloaddition |
| 01/10/2008 | US20080008690 AAV virions with decreased immunoreactivity and uses therefor |
| 01/10/2008 | DE10161577B4 Verfahren zur Renaturierung von Proteinen Process for the renaturation of proteins |
| 01/09/2008 | EP1876184A1 A method for isolating and purifying immuno-modulating polypeptide from cow placenta |
| 01/09/2008 | EP1875244A2 Proliferation of muc1 expressing cells |
| 01/09/2008 | EP1875237A2 Docetaxel immunoassay |
| 01/09/2008 | EP1874933A2 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein |
| 01/09/2008 | EP1874932A2 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein |
| 01/09/2008 | EP1874825A2 Affinity ligands |
| 01/09/2008 | EP1874799A2 High resolution methods and precipitating reagents for isolating proteins from proteinaceous material |
| 01/09/2008 | EP1874798A1 Basic protein purification tags from thermophilic bacteria |
| 01/09/2008 | EP1874797A1 Method of preparing grafted polylysine dendrimers |
| 01/09/2008 | EP1874796A2 Compositions and methods for treating or preventing overweight or obesity with zinc-charged protein fragments |
| 01/09/2008 | EP1874342A2 Compositions and methods for cancer immunotherapy |
| 01/09/2008 | EP1587843A4 Combinatorial libraries of monomer domains |
| 01/09/2008 | EP1460084B1 Novel peptide sy |
| 01/09/2008 | EP1366060B1 Method of purification of interferon-beta |
| 01/09/2008 | CN101103114A Protein isolation and purification |
| 01/09/2008 | CN101100665A Method for preparing animal general purpose recombinant alpha interferon |
| 01/09/2008 | CN101100664A Method for preparing recombinant canine alpha-type interferon |
| 01/08/2008 | US7317129 Chemical synthesis of reagents for peptide coupling |
| 01/08/2008 | US7317090 Inhibiting binding of interleukin-4 (IL-4) to an IL-4 Receptor; suppressing an IL-4-dependent immune or inflammatory response in a mammal |
| 01/08/2008 | US7317088 PRO5993 polypeptides |
| 01/08/2008 | US7317085 Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby |
| 01/08/2008 | US7317083 PRO4501 polypeptides |
| 01/08/2008 | US7317081 PRO4371 polypeptides |
| 01/08/2008 | US7317074 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by adipocyte cells; for release of proteoglycans from cartilage |
| 01/08/2008 | US7316919 Composite materials comprising supported porous gels |
| 01/08/2008 | CA2388716C Process for the purification of pharmacologically active proteins through cationic exchange chromatography |
| 01/08/2008 | CA2228060C Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics |
| 01/08/2008 | CA2203631C Cyclic peptide obtained from actinomyces s. nobilis useful as therapeutic agent |
| 01/05/2008 | WO2008003836A1 Use of functionalized onium salts for the synthesis of peptides |
| 01/05/2008 | CA2596419A1 Use of functionalized onium salts for peptide synthesis |
| 01/03/2008 | WO2008002235A1 Protein purification and identification |
| 01/03/2008 | WO2008001888A1 Method for pre-treatment of serum for analysis of sugar chain |
| 01/03/2008 | WO2008001837A1 Method for purification of oligopeptide |
| 01/03/2008 | WO2008001353A1 Virus removal by nanofiltration |
| 01/03/2008 | WO2008000641A1 Pseudo proline dipeptides |
| 01/03/2008 | WO2007130275A3 Composition and method for the release of protected peptides from a resin |
| 01/03/2008 | WO2007104934A3 Protein folding |
| 01/03/2008 | WO2005079232A3 A METHOD FOR THE PRODUCTION OF AN ERYTHROPOIETIN ANALOG-HUMAN IgG FUSION PROTEINS IN TRANSGENIC MAMMAL MILK |
| 01/03/2008 | WO2005032476A3 Methods and compositions for cpg15-2 |
| 01/03/2008 | WO2005010166A3 P450 oxygenases and methods of use |
| 01/03/2008 | WO2004081226A3 Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use |
| 01/03/2008 | WO2003095473A3 Peptides and methods for cell death regulation |
| 01/03/2008 | WO2003085085A3 Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen |
| 01/03/2008 | US20080005813 Polypeptide Having Function of Cinnamyl Alcohol Dehydrogenase, Polynucleotide Encoding the Polypeptide and Those Uses |
| 01/03/2008 | US20080004433 Characterization of the GSK-3beta protein and methods of use thereof |
| 01/03/2008 | US20080004429 Insulinotropic peptide synthesis using solid and solution phase combination techniques |
| 01/03/2008 | US20080003673 Novel human proteases and polynucleotides encoding the same |
| 01/03/2008 | US20080003659 Reversible Binding Surface |
| 01/03/2008 | US20080003614 Mitochondrial anti-viral signaling protein; activates the NF- kappa B and IRF families of transcription factors to induce interferons in viral infected cells to clear viral infection |
| 01/03/2008 | US20080003237 Gram Positive Bacterial Cells Comprising a Disrupted Flagellin Gene, Flagellin-Based Fusion Proteins and Use in Removal of Metal Ions from a Liquid |
| 01/03/2008 | DE3890998B4 Neutrophilenaktivierungsfaktor, Verfahren zu seiner Herstellung und ihn enthaltende pharmazeutische Zusammensetzung Neutrophilenaktivierungsfaktor, process for its preparation and pharmaceutical composition containing it |
| 01/03/2008 | DE102006029830A1 Growing of deuterated alanine doped triglycine sulfate monocrystals from a solution for night vision device, comprises arranging a crystal holder in a chamber of a device and pumping the solution in a circulation with the chamber |